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Previous work from our group and others utilizing animal models have demonstrated long-
lasting structural and functional alterations in the meso-cortico-striatal dopamine pathway
following prenatal cocaine (PCOC) treatment.We have shown that PCOC treatment results
in augmented D1-induced cyclic AMP (cAMP) and cocaine-induced immediate-early gene
expression in the striatum of adult mice. In this study we further examined basal as well as
cocaine or D1-induced activation of a set of molecules known to be mediators of neuronal
plasticity following psychostimulant treatment, with emphasis in the dorsal striatum (Str)
and nucleus accumbens (NAc) of adult mice exposed to cocaine in utero. Basally, in the Str
ofPCOCtreatedmicethereweresigniﬁcantlyhigherlevelsof(1)CREBandSer133P-CREB
(2)Thr34P-DARPP-32and(3)GluA1andSer845P-GluA1whencomparedtoprenatalsaline
(PSAL) treated mice. In the NAc there were signiﬁcantly higher basal levels of (1) CREB
and Ser133 P-CREB, (2) Thr202/Tyr204 P-ERK2, and (3) Ser845 P-GluA1. Following acute
administration of cocaine (15mg/kg, i.p.) or D1 agonist (SKF 82958; 1mg/kg, i.p.) there
were signiﬁcantly higher levels of Ser133 P-CREB,Thr34 P-DARPP-32, andThr202/Tyr204
P-ERK2 in the Str that were evident in all animals tested. However, these cocaine-induced
increases in phosphorylation were signiﬁcantly augmented in PCOC mice compared to
PSAL mice. In sharp contrast to the observations in the Str, in the NAc, acute administra-
tion of cocaine or D1 agonist signiﬁcantly increased P-CREB and P-ERK2 in PSAL mice, a
response that was not evident in PCOC mice. Examination of Ser 845 P-GluA1 revealed
that cocaine or D1 agonist signiﬁcantly increased levels in PSAL mice, but signiﬁcantly
decreased levels in the PCOC mice in both the Str and NAc.We also examined changes in
brain-derived neurotrophic factor (BDNF). Our studies revealed signiﬁcantly higher levels
of the BDNF precursor, pro-BDNF , and one of its receptors,TrkB in the Str of PCOC mice
compared to PSAL mice. These results suggest a persistent up-regulation of molecules
critical to D1 and BDNF signaling in the Str of adult mice exposed to cocaine in utero.
These molecular adaptations may underlie components of the behavioral deﬁcits evident
in exposed animals and a subset of exposed humans, and may represent a therapeutic
target for ameliorating aspects of the PCOC-induced phenotype.
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INTRODUCTION
Over the past 25years since crack cocaine became a drug com-
monly abused by pregnant women, multiple clinical, and pre-
clinical studies have identiﬁed alterations in fetal brain devel-
opment with lasting consequences on brain structure and func-
tion resulting from prenatal cocaine (PCOC) exposure (Kosofsky
et al., 1994; reviewed in Trask and Kosofsky, 2000; Kosofsky and
Hyman, 2001). Identiﬁcation of a prenatal drug-induced pheno-
type uniquely attributable to intrauterine cocaine exposure has
been elusive. Speciﬁcally, only a subset of exposed infants and
children demonstrate persistent deﬁcits, and when they do, may
manifest ongoing behavioral abnormalities in subtle neurobehav-
ioral domains including deﬁcits in“Affect,Attention,Arousal,and
Action” (the 4A’s: see Lester, 1998; Bada et al., 2007). Speciﬁcally,
PCOC exposure has been shown to result in subtle reductions
in IQ and cognitive development (Alessandri et al., 1998; Lester
et al.,1998),delayed language development (Beeghly et al.,2006),
andimpairmentsintasksrequiringsustainedattention(Accornero
et al.,2007). Such studies support the idea that intrauterine expo-
suretococainemostprofoundlyaltersattention,arousal,andreac-
tivity,functions that may negatively impact learning and memory
in exposed offspring (Mayes et al., 1998). The implications for
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public policy are far reaching, as when such deﬁcits are evident
in PCOC-exposed individuals they may require longer perina-
tal hospitalizations and associated increments in healthcare costs
(Behnke et al., 1997), as well as increased special education needs
and associated expenses (Lester et al., 1998; Levine et al., 2008),
making prevention of prenatal exposure to cocaine, and early
identiﬁcation and treatment of resulting adverse outcomes a high
priority.
As the primary molecular targets of cocaine action are the
uptake pumps for the monoamines dopamine, serotonin, and
to a lesser extent norepinephrine (Uhl et al., 2002), neurochemi-
cal systems which mediate cocaine-induced behaviors, persistent
alterations in aminergic function have been suggested as con-
tributingtothePCOC-inducedphenotype(Mayes,2002).Animal
models, including work performed in mice (Wilkins et al., 1998),
rats (Spear et al., 2002), rabbits (Harvey, 2004), and non-human
primates (Lidow and Song, 2001) have been particularly helpful
in identifying the independent contribution of cocaine to such
neurobehavioral deﬁcits, as well as in understanding the basic
mechanisms underlying such changes (Malanga, 1999). In par-
ticular,rodent models have demonstrated persistent alterations in
dopaminergic (DA) signaling, primarily via the D1 receptor, in
adult animals following PCOC treatment (Friedman and Wang,
1998; Unterwald et al.,2003; Stanwood and Levitt,2007; Malanga
et al.,2008; Tropea et al.,2008a).
The cascade of molecular events initiated in the striatum
(Str) and nucleus accumbens (NAc) following acute exposure of
adult animals to cocaine has been well characterized (reviewed
in McGinty et al., 2008). Speciﬁcally, a wealth of experimental
data identiﬁes a rapid and robust activation of D1-like cell sur-
face receptors activating intracellular signaling pathways to affect
speciﬁc patterns of gene expression (Self et al., 1996), and alter-
ations thereof in mice genetically engineered to be deﬁcient in D1
mediated signal transduction in the Str (Drago et al., 1996). High
throughputarray-basedmethodshaveidentiﬁedsetsofgenesacti-
vated in the Str and NAc following acute cocaine exposure that
are distinguishable from those following repeated cocaine expo-
sures (Renthal et al., 2009), emphasizing the persistent molecular
adaptations, in part via recurrent D1-mediated neuronal stimu-
lation, in contributing to the “addicted state” (Chao and Nestler,
2004).
Onephenomenonthathasbeenextensivelyinvestigatedinani-
mal models has been the process of sensitization, by which prior
psychostimulant exposure augments the subsequent response to
a challenge dose of drug (reviewed in Kalivas et al., 1998). Work
from our lab and others has identiﬁed that signaling via second
messenger molecules such as (P-)CREB,(P-)DARPP-32,(P-)ERK,
and (P-)GluA1 in the Str and NAc are persistently altered follow-
ingrecurrentpsychostimulantexposure,andmayunderlieaspects
of the “sensitized state.” These data raise the possibility that fol-
lowing PCOC exposure, such signaling pathways may similarly
demonstrate persistent dysregulation, and may render adult ani-
mals susceptible to altered behavioral responses to subsequent
administration of drugs of abuse (reviewed in Crozatier et al.,
2003; Malanga and Kosofsky,2003).
Consistent with this thinking, we have focused our attention
on the effect of PCOC treatment on persistent dysregulation of a
set of target genes known to mediate aspects of synaptic plasticity,
including growth factors (e.g., brain-derived neurotrophic factor,
BDNF), immediate-early genes (e.g., zif-268), and synaptic scaf-
folding proteins (e.g., homer 1a). Previous work from our group
analyzing the Str and NAc has focused on the role of dopamine
D1-mediated cyclic AMP (cAMP) regulation, and demonstrated
increased cocaine-mediated induction of both zif-268 and homer
1a mRNA in the Str, but not the NAc of adult PCOC treated vs.
prenatal saline (PSAL) treated mice (Tropea et al., 2008a). Here
we extend that work to identify that an additional set of signaling
molecules activated via D1 stimulation including (P-)CREB, (P-
)DARPP-32,(P-)ERK,and(P)GluA1aredifferentiallyactivatedin
the Str and NAc of adult PCOC vs. PSAL mice. We found that
following acute administration of cocaine (15mg/kg, i.p.) or D1
agonist (SKF 82958; 1mg/kg, i.p.) there were signiﬁcantly higher
levels of Ser133 P-CREB,Thr34 P-DARPP-32,and Thr202/Tyr204
P-ERK2evidentintheStrinbothprenataltreatmentgroups.How-
ever,this increase was signiﬁcantly augmented in PCOC vs. PSAL
mice. In sharp contrast, neither acute cocaine nor SKF 82958-
induced phosphorylation of CREB or ERK2 in the NAc of PCOC
mice, but did in the NAc of PSAL mice. Following acute adminis-
tration of cocaine or D1 agonist there were signiﬁcantly increased
levels of Ser845 P-GluA1 in both the Str and NAc of PSAL mice,
in contrast to signiﬁcantly decreased levels of Ser845 P-GluA1 in
both the Str and NAc of PCOC mice. In parallel we have addi-
tionally identiﬁed that the growth factor pro-BDNF, and TrkB, a
BDNF receptor, are upregulated in the Str but not NAc of adult
PCOC mice.
Taken together our data identiﬁes region-speciﬁc patterns (i.e.,
Str vs. NAc) in the constitutive expression of a set of proteins and
phospho-proteins, as well as their pattern of expression follow-
ing acute administration of cocaine or the D1 agonist SKF 82958,
whichdistinguishPCOCfromPSALmice.Thedifferentialpattern
of constitutive as well as inducible proteins and phospho-proteins
that we have identiﬁed suggest a persistent molecular memory
in PCOC mice evidenced as a cocaine-induced augmentation in
CREB and ERK phosphorylation in the Str, blunting of CREB
and ERK phosphorylation in the NAc, and de-phosphorylation
of GluA1 in both the Str and NAc, all via D1 mechanisms. Such
data extends the idea that recurrent drug exposure induces abnor-
mal synaptic learning and memory (Berke and Hyman, 2000;
Hyman and Malenka, 2001; Hyman, 2005) in a developmental
context such that adaptations in Str and NAc neuronal function
established in the womb may“feed forward”to induce alterations
in dopaminergic neurotransmission and associated behaviors in
adulthood.
MATERIALS AND METHODS
PRENATAL COCAINE TREATMENT
Prenatal treatments were performed as previously described (Tro-
pea et al., 2008b). Brieﬂy, timed-pregnant Swiss Webster dams
(Taconic Labs, New York) were assigned to one of two treatment
groups and received twice-daily subcutaneous (SC) injections (at
7:00 AM and 7:00 PM) from embryonic (E) day E8 to E17,
inclusive, of cocaine HCl (Sigma-Aldrich, St. Louis, MO, USA;
20mg/kg/injection, SC, dissolved in saline) totaling 40mg/kg per
day (offspring referred to as PCOC for prenatal cocaine treated)
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or 0.9% saline (offspring referred to as PSAL for prenatal saline
treated). All pups were surrogate fostered to control dams (Black
SwissWebster; Taconic Labs),which had delivered within the pre-
vious 48h. Litters were culled to a maximum of 10 pups per dam.
Animals were weaned at 28days in to same sex cages, at which
point female animals were euthanized. Only one male animal per
litterwasusedforanyof thestudiesreported,therebyavoidingthe
problem of litter effects resulting in “oversampling.” As a result,
the individual animal’s data was the unit of statistical measure,
and represented the “litter mean” for that data point. All exper-
imental protocols were approved by the Weill Cornell Medical
College Institutional Animal Care and Use Committee, and were
in accordance with NIH directives for animal studies.
WESTERN BLOT ANALYSES
Westernblotanalysiswasperformedaspreviouslydescribed(Tro-
peaetal.,2008b).Brieﬂy,adult(P60)malePSALandPCOCtreated
mice were injected with saline, cocaine (15mg/kg, i.p.), or the D1
agonist SKF 82958 (1mg/kg, i.p.) followed 15min later by rapid
decapitation,braindissectionandfreezingat−40˚Cinisopentane.
All brains were serially cut rostro-caudally in a freezing cryostat
to obtain bilateral punches of the dorsal striatum (Str; A/P +1.7
to +1.2; Paxinos and Franklin, 2003), the NAc (A/P stereotactic
coordinates +1.7 to +1.2), bilateral 0.5mm deep tissue punches
of somato-sensory cortex (CTX; A/P +1.7 to +1.2mm), medial
prefrontalcortex(mPFC;A/P+1.98to+1.54mm),andunilateral
ventral tegmental area (VTA; A/P −3.16 to −3.64mm) punches.
All tissue punches were obtained with a 17-gage stainless steel
stylet.
For pro- and mature BDNF,TrkB,and p75Western blot analy-
ses, tissue from the NAc, Str, mPFC, and VTA, of untreated
PSAL and PCOC animals was used. Tissue was sonicated in SDS
sample buffer (1% SDS in TE pH 7.4) containing protease and
phosphatase inhibitors and 25μg of protein was separated on
a 15% gel along with a Kaleidoscope-prestained standard (Bio-
Rad, Hercules, CA, USA). For all other protein analyses, protein
lysates were isolated on a 12% gel. Blots were incubated in pri-
mary antibody [CREB (1:850), Ser133 P-CREB (1:850), DARPP-
32 (1:1000), Thr34 P- DARPP-32 (1:500), Thr75 P-DARPP-32
(1:500), Thr202/Tyr204 P-ERK1/2 (1:1000), ERK1/2 (1:1000),
Ser 845 P-GluA1 (1:850), GluA1 (1:1000), Cell Signaling, Dan-
vers, MA, USA; BDNF N-20 (1:200), Santa Cruz Biotechnology,
Santa Cruz, CA, USA; TrkB (1:500), Upstate Cell Signaling Solu-
tions, Lake Placid, NY, USA; p75 (1:1000), NR2B (1:1000), actin
(1:20,000), Chemicon, Temecula, CA, USA] for 12–48h at 4˚C.
Secondaryantibodyincubationswereperformedatroomtemper-
atureinblockingbufferfor1h(horseradishperoxidase-linkedIgG
conjugated goat anti-rabbit 1:5000 for CREB, P-CREB, DARPP-
32, Thr34 P-DARPP-32, BDNF, TrkB, and NR2B and 1:10,000 for
p75, or horse anti-mouse 1:30,000 for actin, Vector Laboratories,
Burlingame,CA,USA). Membranes were visualized with Western
Lightning Chemiluminescence solution (Perkin Elmer Life Sci-
ence, Boston, MA, USA). Optical density from ﬁlms was analyzed
using NIH Image (NIH, Bethesda, MD, USA). For BDNF, pro-
BDNF bands were analyzed at 30kDa,while mature BDNF bands
were analyzed at 14kDa. To conﬁrm the identity of these bands,
striatal cell lysate and recombinant BDNF protein (generously
supplied by Dr. Francis Lee, Weill Cornell Medical College, New
York, NY, USA) was analyzed as shown in Figure 3A.
STATISTICAL ANALYSES
Gestational data were analyzed using t-test, while western blot
data were analyzed by one-way ANOVA, and when signiﬁcant at
p <0.05 level,post hoc comparisons (Bonferroni–Dunn) between
treatment groups was performed.
RESULTS
GESTATIONAL DATA
TheaveragepercentageweightgainofdamsfromE8toE17andthe
number of live pups per litter for each prenatal treatment group
were recorded. PCOC dams gained less weight during pregnancy
(p <0.0001),and gave birth to less live pups per litter (p <0.001)
as compared to PSAL dams (Table 1).
ALTERED PROTEIN PHOSPHORYLATION LEVELS IN THE Str OF PCOC
MICE
Toexamineproteinphosphorylationlevels,adultPSALandPCOC
mice were administered saline (PSAL sal and PCOC sal), cocaine
(PSAL coc and PCOC coc) or the dopamine agonist, SKF 82958
(SKF; PSAL skf and PCOC skf). Fifteen minutes later mice were
rapidly decapitated and tissue was isolated in a cryostat for West-
ern blot analysis of the Str (Figure 1) and NAc (Figure 2). To
evaluate the effect of PCOC exposure on basal differences in pro-
tein levels of CREB/Ser133 P-CREB,DARPP-32/Thr34 and Thr75
P-DARPP-32, ERK2/Thr202/Tyr204 P-ERK, and GluA1/Ser 845
P-GluA1 we compared PCOC sal vs. PSAL sal mice. The effect of
PCOC exposure on cocaine and dopamine D1 signaling was eval-
uated by comparing cocaine- and D1 agonist,SKF 82958-induced
changes in phospho-protein levels (P-CREB, Thr34- and Thr75-
DARPP-32,P-ERK,and P-GluA1) in PCOC coc vs. PSAL coc,and
PCOC skf vs. PSAL skf,respectively.
Striatum
Examinationofbasallevelsoftotalandphospho-proteinsrevealed
signiﬁcantly higher levels of CREB and P-CREB in PCOC vs.
PSAL mice (Figures 1A,B, respectively). Examination of DARPP-
32 revealed no effect of PCOC on basal DARPP-32 levels
(Figure 1E). However, there were signiﬁcantly higher basal lev-
els of Thr34 P-DARPP-32 in PCOC mice compared to PSAL mice
T a b l e1|E f f e c to fp r enatal cocaine treatment on dam weight gain and
offspring number.
Prenatal
Treatment
Average percentage
weight gain of dam
Average number of
live pups per litter
PSAL 79.7±2.46 13.8±0.48
PCOC 61.6±2.42* 11.5±0.37†
The average percentage weight gain of dams from E8 to E17 and the number of
live pups born per litter for each prenatal treatment group were recorded. PCOC
vs. PSAL dams on average had a smaller percentage weight gain during preg-
nancy (*p<0.0001) and had a lower average number of live born pups per litter
(
†p<0.001). All values represent the mean±SEM.
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FIGURE1|E f f e c to fp r enatal cocaine treatment on basal, cocaine- and
SKF 82958-induced protein phosphorylation in the striatum of adult
mice. Representative immunoblots and quantitative analysis of protein
[(A) CREB; (E) DARPP-32; (K) ERK2; (O) GluA1] and phospho-protein
[(B–D) P-CREB; (F–J)Thr 34 andThr 75 P-DARPP-32; (L–N) P-ERK2; (P–R)
P-GluA1] levels normalized to actin (mean optical density±SEM). Protein
levels were measured in prenatal saline treated (PSAL) and prenatal
cocaine (PCOC) treated mice administered normal saline (sal), cocaine
(15mg/kg; coc) or D1 agonist, SKF 82958 (1mg/kg; skf) as adults. Data are
represented as percentage of PSAL mice treated with saline (PSAL sal).
†p <0.05,
††p <0.01 PCOC pretreatment groups vs. PSAL pretreatment
groups. *p <0.05, **p <0.01, coc or skf treated mice vs. sal treated mice
within the same prenatal treatment. Error bars represent±SEM. N =6–8
mice/group.
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FIGURE2|E f f e c to fp r enatal cocaine treatment on basal, cocaine- and
SKF 82958-induced protein phosphorylation in the nucleus
accumbens of adult mice. Representative immunoblots and quantitative
analysis of protein [(A) CREB; (E) DARPP-32; (K) ERK2; (O) GluA1] and
phospho-protein [(B–D) P-CREB; (F–J)Thr 34 andThr 75 P-DARPP-32;
(L–N) P-ERK2; (P–R) P-GluA1] levels normalized to actin (mean optical
density±SEM). Protein levels were measured in prenatal saline (PSAL)
treated and prenatal cocaine (PCOC) treated mice administered normal
saline (sal), cocaine (15mg/kg; coc) or D1 agonist, SKF 82958 (1mg/kg;
skf) as adults. Data are represented as percentage of PSAL mice treated
with saline (PSAL sal).
†p <0.05,
††p <0.01 PCOC pretreatment groups vs.
PSAL pretreatment groups. *p <0.05, **p <0.01, coc or skf treated mice
vs. sal treated mice within the same prenatal treatment. Error bars
represent±SEM. N =6–8 mice/group.
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(Figure 1F) with a trend toward lower levels of Thr75 P-DARPP-
32 (Figure 1G). Examination of ERK2 revealed no change in the
basal levels of ERK2 or P-ERK2 in PCOC mice (Figures 1K,L,
respectively). Examination of GluA1 revealed signiﬁcantly higher
levels of basal GluA1 and P-GluA1 in PCOC mice compared to
PSAL mice (Figures 1O,P,respectively).
Examination of cocaine or SKF 82958-induced changes in
phospho-protein levels revealed that cocaine or SKF 82958 sig-
niﬁcantly increased P-CREB in PSAL and PCOC mice compared
to saline treated mice (Figure 1C, PSAL coc vs. PSAL sal and
PCOCcocvs.PCOCsalandFigure1D,PSALskf vs.PSALsaland
PCOC skf vs. PCOC sal, respectively). Furthermore, the increase
in P-CREB observed in PCOC mice was signiﬁcantly augmented
compared to PSAL mice (Figure 1C, PCOC coc vs. PSAL coc;
Figure 1D, PCOC skf vs. PSAL skf). Similarly cocaine or SKF
82958 treatment signiﬁcantly increased Thr34 P-DARPP-32 levels
in PSAL and PCOC mice (Figures 1G,I, respectively) with sig-
niﬁcantly augmented levels evident in PCOC mice compared to
that observed in PSAL mice (Figure 1G, PCOC coc vs. PSAL coc;
Figure 1I, PCOC skf vs. PSAL skf). Cocaine or SKF 82958 treat-
ment signiﬁcantly decreased Thr75 P-DARPP-32 levels in PSAL
mice (Figures 1H,J, respectively). In PCOC mice, cocaine treat-
ment had no effect on Thr75 P-DARPP-32 levels (Figure 1H)
whereas SKF 82958 signiﬁcantly decreased Thr75 P-DARPP-32
levels (Figure 1J) to levels that were signiﬁcantly lower than that
seen in PSAL mice (Figure 1J, PCOC skf vs. PSAL skf). Exam-
ination of P-ERK2 levels revealed that cocaine or SKF 82958
treatment signiﬁcantly increased P-ERK2 levels in both PSAL and
PCOC mice (Figures 1M,N, respectively) with signiﬁcantly aug-
mented levels evident in PCOC mice compared to PSAL mice
(Figure 1M, PCOC coc vs. PSAL coc; Figure 1N, PCOC skf vs.
PSAL skf). Examination of P-GluA1 levels revealed that cocaine
or SKF 82958 treatment signiﬁcantly increased P-GluA1 levels
in PSAL mice (Figures 1Q,R, respectively). However, interest-
inglyinPCOCmice,cocaineorSKF82958treatmentsigniﬁcantly
decreased P-GluA1 levels (Figures 1Q,R, respectively), and these
levels were signiﬁcantly lower than that observed in PSAL mice
(Figure 1Q, PCOC coc vs. PSAL coc; Figure 1R, PCOC skf vs.
PSAL skf).
Nucleus accumbens
Examinationofbasallevelsoftotalandphospho-proteinsrevealed
signiﬁcantly higher levels of CREB and P-CREB in the NAc of
PCOC mice compared to PSAL mice (Figures2A,B,respectively).
Examination of basal DARPP-32 levels revealed no difference in
DARPP-32, Thr34 P-DARPP-32 or Thr75 P-DARPP-32 between
PSAL and PCOC mice (Figures 2E,F, respectively). Examination
of ERK2 revealed no change in basal ERK2 in PCOC mice com-
pared to PSAL mice (Figure 2K), but signiﬁcantly higher P-ERK2
levels in PCOC mice compared to PSAL mice (Figure 2L). Simi-
larly, examination of GluA1 levels revealed no difference in basal
GluA1 levels (Figure 2O) between prenatal treatment groups.
However, Ser 845 P-GluA1 levels were signiﬁcantly higher in the
NAc of PCOC mice compared to PSAL mice (Figure 2P).
Examination of cocaine or SKF 82958-induced changes in
phospho-protein levels revealed that cocaine or SKF 82958
treatment signiﬁcantly increased P-CREB levels in PSAL mice
compared to saline treated mice (Figure 2C, PSAL coc vs. PSAL
sal and Figure 2D, PSAL SKF vs. PSAL sal), a response that
was not evident in PCOC mice (Figures 2C,D, respectively).
Cocaine or SKF 82958 treatment signiﬁcantly increased Thr34
P-DARPP-32levelsinPSALandPCOCmicewithnodifferencein
levels between the two prenatal treatment groups (Figures 2G,I,
respectively). Cocaine or SKF 82958 administration signiﬁcantly
decreased Thr75 P-DARPP-32 levels in PSAL mice, with a trend
toward lower levels in PCOC mice evident (Figures 2H,J, respec-
tively).Examinationof P-ERK2levelsrevealedthatcocaineorSKF
82958 treatment signiﬁcantly increased P-ERK2 levels in PSAL
mice compared to saline treated mice (Figures 2M, PSAL coc vs.
PSAL sal and Figures 2N, PSAL SKF vs. PSAL sal), a response
that was not evident in PCOC mice (Figures 2M,N, respectively.
Examination of P-GluA1 revealed that cocaine or SKF 82958
administration increased P-GluA1 in PSAL mice (Figures 2Q,R,
respectively) while either cocaine or SKF 82958 treatment signif-
icantly decreased P-GluA1 in PCOC mice (Figures 2Q,R, respec-
tively).SKF82958-inducedP-GluA1levelsweresigniﬁcantlylower
in PCOC mice compared to PSAL mice (Figure 2R, PCOC skf vs.
PSAL skf).
ALTERED BDNF IN THE Str OF PCOC MICE
We next examined levels of pro- and mature BDNF in the Str and
NAc of PCOC vs. PSAL mice, along with levels in the mPFC and
VTA, anatomical regions where BDNF is synthesized and trans-
ported to those targets (Conner et al., 1997; Altar and DiStefano,
1998).Toidentifythepreciseproteinbandsthatcorrespondtopro-
vs.matureBDNFweﬁrstcomparedBDNFWesternblotscontain-
ingstriatalproteinlysateswithrecombinantBDNFproteinlysates
(Figure 3A). A pro-BDNF protein band at 30kDa and mature
BDNF protein band at 14kDa was used to compare levels of the
two proteins in protein lysates obtained from mPFC, Str, NAc,
and VTA tissue of PCOC vs. PSAL mice. Western blots revealed
signiﬁcantly higher levels of pro-BDNF in the Str of PCOC mice
compared to PSAL mice (Figure 3B). No signiﬁcant differences
in pro-BDNF levels were observed for any other regions sampled.
Examinationof matureBDNFlevelsrevealednosigniﬁcantdiffer-
encesbetweenPCOCandPSALmiceinanyoftheregionssampled
(Figure 3C).
We next examined the effect of prenatal treatment on the lev-
els of the BDNF receptors TrkB, p75, and NR2B in the Str and
NAc of PCOC vs. PSAL mice (Figure 4). TrkB levels were signif-
icantly higher in the striatum of PCOC compared to PSAL mice
(Figure 4A), while in the NAc there was no signiﬁcant difference
in TrkB levels between the two prenatal treatment groups. No sig-
niﬁcant differences were observed in p75 protein levels in PCOC
vs. PSAL mice in the Str or NAc (Figure 4B). Similarly, examina-
tion of NR2B, a gene regulated by the pro-BDNF pathway (Woo
etal.,2005)revealednosigniﬁcantdifferencesbetweenPCOCand
PSAL mice in either brain region (Figure 4C).
DISCUSSION
DA SIGNALING IN THE Str AND NAc OF PCOC MICE
We, like others, ﬁnd that acute cocaine administration increases
protein phosphorylation of CREB, DARPP-32, ERK2, and GluA1
in the Str and NAc of adult mice via a D1 mechanism
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FIGURE 3 | Pro-BDNF protein levels are higher in the striatum of prenatal
cocaine treated mice. (A) Immunoblot showing pro- and mature
brain-derived neurotrophic factor (BDNF) from recombinant protein and
striatal protein lysates. Pro-BDNF was detected at 30kDa and mature BDNF
at 14kDa; (B,C) Pro- and mature BDNF levels were measured in the medial
prefrontal cortex (mPFC), dorsal striatum (Str), nucleus accumbens (NAc), and
ventral tegmental area (VTA) of adult mice prenatally treated with saline
(PSAL) or cocaine (PCOC). Protein levels were normalized to actin. Striatum of
PCOC mice contained signiﬁcantly higher amounts of pro-BDNF (B)
compared to PSAL mice (*p <0.05) with no difference in levels of mature
BDNF (C). All other regions showed no difference in the levels of pro- or
mature BDNF . Error bars represent the mean±SEM. N =4–6 mice/group.
FIGURE 4 |TrkB receptor protein levels are higher in the striatum of
prenatal cocaine (PCOC) treated mice.Total protein levels of (A) tyrosine
kinase B (TrkB), (B) p75 receptors and (C) NR2B receptor subunits were
analyzed in the dorsal striatum (Str) and nucleus accumbens (NAc) of prenatal
saline (PSAL) treated vs. PCOC treated adult mice. (A)TrkB receptor levels
were signiﬁcantly higher in the striatum of PCOC mice compared to PSAL
mice (*p <0.05), while no difference was observed in the NAc. No
differences in the levels of p75 (B) or NR2B (C) were observed in the Str or
NAc of PCOC mice compared to PSAL mice. Error bars represent±SEM.
N =5–6 mice/group.
(Fienberg et al., 1998; Zhang et al., 2002a,b; Gerfen et al., 2008;
Guan et al., 2009). Speciﬁcally, following acute administration of
cocaine (15mg/kg, i.p.) or D1 agonist (SKF 82958; 1mg/kg, i.p.)
there were signiﬁcantly higher levels of Ser133 P-CREB, Thr34
P-DARPP-32, Thr202/Tyr 204 P-ERK2, and Ser845 P-GluA1, as
well as lower levels of Thr75 P-DARPP-32 evident in the Str
and NAc of PSAL mice. Interestingly, in the Str of PCOC mice,
administration of cocaine or D1 agonist further augmented the
phosphorylation of CREB,DARPP-32 at Thr34,and ERK,but led
toade-phosphorylationofDARPP-32atThr75andofGluA1.The
augmented activation of this signaling cascade is a likely mech-
anism for the increased expression of both zif-268 and homer
1a mRNA observed in the striatum of PCOC mice following
acute cocaine administration (see Figure 5), which may also be
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FIGURE5|P r oposed model for adaptations in D1 receptor and BDNF
signaling pathways in the striatum of prenatal cocaine treated mice.
Prenatal cocaine treatment results in enhanced signaling via dopamine D1
andTrkB receptors in the striatum of adult mice via persistent adaptations
in a coordinately regulated set of pre-synaptic, synaptic, and post-synaptic
molecules. Gray arrows represent long-term adaptations seen in adult mice
following prenatal cocaine treatment.
attributable to a persistent enhancement in the coupling of D1
with cAMP (Tropea et al., 2008a). These data are discrepant with
those reported in a rabbit model of PCOC exposure, in which
thereisdemonstrationof attenuatedD1activationviauncoupling
of GalphaS subunits from D1 receptors, resulting in enhanced
internalization of D1 subunits (Wang et al., 1995; Jones et al.,
2000; Stanwood and Levitt, 2007). While such data from rab-
bitssuggestsattenuateddopaminergicactivationfollowingPCOC
exposure, this same rabbit model has additionally provided evi-
dence of enhanced DARPP-32 phosphorylation at Thr34 (Zhen
et al., 2001), data concordant with our current ﬁndings in mice.
Results from different models of PCOC exposure may differ as a
result of species (e.g., mice vs. rabbits), route (SC vs. IV), dose
and gestational timing of cocaine exposure,or brain regions stud-
ied (e.g.,Str/NAc vs. Cingulate Cortex). Further studies should be
directedatelucidatingthecauseof suchdifferences,andtheextent
to which they adequately model aspects of the clinical problem.
WealsofoundsigniﬁcantdifferencesinPCOCmicewhencon-
trasting the phosphorylation of both CREB and ERK in the Str vs.
NAc following administration of cocaine or D1 agonist; there was
enhanced phosphorylation of CREB and ERK evident in the Str
of PCOC mice, in contrast to blunted phosphorylation of CREB
and ERK in the NAc of PCOC mice. It is possible that the con-
stitutive increase in P-ERK identiﬁed in the NAc of PCOC mice,
which was not evident in the Str, prevented the subsequent phos-
phorylation of ERK (and perhaps CREB) in the NAc. The blunted
phosphorylation of at least one of these proteins may be related
to our previous observation that acute cocaine administration did
not increase either zif-268 or homer 1a mRNA expression in the
NAc of PCOC mice (Tropea et al.,2008a).
P-GluA1 SIGNALING IN THE Str AND NAc
In both the Str and NAc of PCOC mice,where increased constitu-
tive expression of P-GluA1 was evident,administration of cocaine
or SKF 82958 resulted in decreased GluA1 phosphorylation. This
is in sharp contrast to PSAL mice, in which administration of
cocaineorSKF82958resultedinincreasedexpressionof P-GluA1.
Again, it is possible that the constitutive increase in P-GluA1
identiﬁed in both the Str and NAc of PCOC mice,prevented sub-
sequent phosphorylation of GluA1 in both regions. Recent work
has suggested that increased P-GluA1 sequesters this receptor in
the cytoplasm,thereby preventing insertion of a functional recep-
tor into the membrane, a phenomena that has been correlated
with the sensitized state (for review see Mazzucchelli et al., 2002;
Wolf and Ferrario, 2010). The mechanism that contributes to the
constitutive increase in P-ERK evident in the Str of PCOC mice is
presumably different than the mechanism that contributes to the
constitutiveincreaseinP-GluA1evidentinboththeStrandNAcof
PCOCmice,butbothmaybemediatedbyepigeneticmechanisms.
BDNF AND TrkB SIGNALING IN THE Str VS. NAc OF PCOC MICE
We see increases in the constitutive expression of pro-BDNF and
TrkBintheStr,butnotintheNAcof PCOCmice.However,wedo
not see changes in the expression of mature BDNF, p75, or NR2B
receptorsubunits,identifyingaregionalaswellasmolecularspeci-
ﬁcity in the BDNF signaling pathway that is persistently altered in
PCOC mice. Work from others (Yang et al., 2009) suggests that
pro-BDNF preferentially binds the p75 receptor, whereas mature
BDNFpreferentiallybindstheTrkBreceptor.Wearethereforepur-
suing additional experiments to identify the functional relevance
of the increased constitutive expression of pro-BDNF and TrkB in
the adult Str, which may be a result of enhanced cortico-striatal
projections, which are the predominant source of striatal BDNF
(Conner et al., 1997; Altar and DiStefano, 1998). Interestingly,
recent data obtained from ex vivo cultures of embryonic mouse
brains suggests that the tangential migration of GABAergic neu-
rons from their site of origin in the ganglionic eminence to their
cortical destination is delayed in the forebrain of mice prenatally
exposed to cocaine, and that supplementation of those cultures
withexogenousBDNFnormalizedthismigration(McCarthyetal.,
2011). Furthermore, cocaine has distinct acute and long-term
effects on BDNF transcription and expression in striatum and
frontal cortex (Liu et al., 2006), which is further complicated by
post-transcriptionalalterationsintheisoformsofBDNFexpressed
(Jiangetal.,2009).Takentogetherthedatasuggeststhatperturba-
tions in the level of BDNF at speciﬁc developmental periods can
have immediate as well as long-lasting implications for neuronal
migrationandmaturation,withimpactonbrainfunctionthatcan
persist into adulthood.
IMPLICATIONS OF OUR MOLECULAR FINDINGS ON BRAIN FUNCTION
What is unknown is whether the differential adaptations in
dopaminergic signaling that persist in the Str and NAc of PCOC
mice evident following acute administration of cocaine we have
reported will enhance their liability for addiction following recur-
rent cocaine exposure as adults. Previous experiments from our
group contrasting PCOC and PSAL mice have identiﬁed alter-
ations in cocaine-induced brain stimulation reward (Malanga
et al., 2008), self-administration (Rocha et al., 2002), conditioned
place preference (Malanga et al., 2007), and locomotor sensitiza-
tion (Crozatier et al., 2003), as well as dopamine release in the
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Str and NAc during that same locomotor sensitization regimen
(Malanga et al., 2009). However, in each study while the PCOC
mice could be distinguished from the PSAL mice, the phenotype
did not dramatically demonstrate an enhanced liability toward
addiction. Such complexity could be attributable to the differen-
tial adaptations in PCOC vs. PSAL mice that we report here in
the Str vs. NAc. This may preclude the progression of habit learn-
ing associated with recurrent drug exposure which is thought to
requiretheexpandedrecruitmentof successivelymoredorsalstri-
atalcircuitsfollowingtheinitialactivationof theNAc(Everittand
Robbins, 2005; Belin and Everitt, 2008; Haber, 2008). In addition,
the liability for addiction in humans is critically dependent on
genetic as well as environmental factors, which may be signiﬁ-
cantly enhanced in offspring prenatally exposed to cocaine, and
may be powerfully interactive with adaptations in Str and NAc
neuronal function as we have described in our mouse model. As
the generation of young adults prenatally exposed to cocaine ini-
tiate their own experiences with drug experimentation, they may
be at greater risk for the ﬁfth“A”– addiction.
Human imaging studies can help to identify the structural and
functional correlates of the behavioral and molecular aberrations
seen in animal models of PCOC exposure (reviewed in Roussotte
et al., 2010). Whole brain MRI has provided evidence for reduc-
tions in parietal and occipital cortical gray matter volumes and a
cocaine dose-dependant reduction in white matter of the corpus
callosum in humans exposed to cocaine in utero (Dow-Edwards
et al.,2006; Rivkin et al.,2008). Callosal volume loss was corrobo-
ra t e di nar o d e n tm o d e la sw e ll( Ma et al.,2009).Attenuated white
matter integrity on DTI imaging of the left frontal callosal and
right frontal projection ﬁbers suggests suboptimal white matter
development in those areas (Warner et al., 2006). Similarly, stud-
ies in opiate-exposed offspring show that white matter integrity
seemstobemostsusceptibletodamageinareasundergoingearlier
CNS development (Walhovd et al., 2010). Analyses of subcortical
structures have revealed a persistent decrease in caudate volume
following prenatal cocaine exposure (Avants et al., 2007). Func-
tional studies using fMRI provide evidence of a 10% reduction
in cerebral blood ﬂow most prominent in posterior and inferior
brain regions of adolescents (Rao et al., 2007). Sheinkopf et al.
(2009) have shown that performance in a go-no go task adoles-
cents who were previously exposed to cocaine in utero showed
a greater activation of right inferior frontal and striatal regions
compared to controls who activated fusiform gyrus and occipi-
tal cortex more prominently, suggesting differences in cognition
and attention in the PCOC-exposed group. Correlations between
reducedfrontalwhitematterandvisuo-spatialandexecutivefunc-
tioning tests (Warner et al., 2006), right parietal volume loss with
visual attention, sensori-motor tasks, and syntax construction,
and left occipital volume loss with poor performance in visual
attention,recognition,andvisuomotortasks(Dow-Edwardsetal.,
2006) suggest PCOC affects visual, sensori-motor, and executive
functions.
A deeper appreciation of the relevance of the persistent mole-
cular adaptations evident in animal models, including that which
we report here, to the results obtained in structural and func-
tional imaging studies performed in humans, will require a bet-
ter understanding of the mechanisms by which such molecular
changes are interactive with genetic factors including common
polymorphisms for genes such as BDNF, which independent of
PCOC exposure may confer enhanced vulnerability vs. resilience
to addiction. Such gene X (fetal) environment interactions may
contribute to aspects of the PCOC phenotype demonstrated in
humans by others, including some of those reported in this mono-
graph. Conceptualizedthisway,intrauterinecocaineexposurecan
be thought of as a pharmacologic means of inducing a state of
“fetal reprogramming” (Barker, 1995) by which molecular path-
ways underlying ongoing brain development are permanently
altered, thereby enhancing an individual’s vulnerability to sub-
sequent disease, in this case addiction. Like with other diseases,
early detection of such enhanced vulnerabilities will provide a
rational starting point for behavioral and perhaps pharmacologic
interventions to prevent expression of disease, which in the case
of prenatal drug exposure may help prevent the problem from
begetting itself.
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